A Combination of Acalabrutinib With R-CHOP for Patient Diffuse Large B-cell Lymphoma (DLBCL)
Clinical trial NCT03571308 · COMPLETED
Trial details
- NCT number
- NCT03571308
- Sponsor
- University Hospital Southampton NHS Foundation Trust
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-02
- Primary completion
- 2020-01-02
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.